Haddow, LJ;
Laverick, R;
Daskalopoulou, M;
McDonnell, J;
Lampe, FC;
Gilson, R;
Speakman, A;
... CIPHER Study Group, .; + view all
(2017)
Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.
AIDS and Behavior
10.1007/s10461-017-1683-z.
(In press).
|
Text
art%3A10.1007%2Fs10461-017-1683-z.pdf - Published version Download (426kB) | Preview |
Abstract
We conducted a cross-sectional study in 448 HIV positive patients attending five European outpatient clinics to determine prevalence of and factors associated with neurocognitive impairment (NCI) using computerized and pen-and-paper neuropsychological tests. NCI was defined as a normalized Z score ≤-1 in at least 2 out of 5 cognitive domains. Participants' mean age was 45.8 years; 84% male; 87% white; 56% university educated; median CD4 count 550 cells/mm(3); 89% on antiretroviral therapy. 156 (35%) participants had NCI, among whom 26 (17%; 5.8% overall) reported a decline in activities of daily living. Prevalence of NCI was lower in those always able to afford basic needs (adjusted prevalence ratio [aPR] 0.71, 95% confidence interval [CI] 0.54-0.94) or with a university education (aPR 0.72, 95% CI 0.54-0.97) and higher in those with severe depressive symptoms (aPR 1.53, 95% CI 1.09-2.14) or a significant comorbid condition (aPR 1.40, 95% CI 1.03-1.90).
Archive Staff Only
 |
View Item |
